Evidence map›Paper›PMID 35783579›Full record

ArticlePhysics and imaging in radiation oncology2022

Corrigendum to "Robustness of radiomic features in magnetic resonance imaging for patients with glioblastoma: Multi-center study" [Phys. Imaging Radiat. Oncol. 22 (2022) 131-136].

Natalia Saltybaeva, Stephanie Tanadini-Lang, Diem Vuong, Simon Burgermeister, Michael Mayinger, Andrea Bink, Nicolaus Andratschke, Matthias Guckenberger, Marta Bogowicz

Abstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in Physics and imaging in radiation oncology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors.

Natalia SaltybaevaDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Stephanie Tanadini-LangDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Diem VuongDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Simon BurgermeisterDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Michael MayingerDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Andrea BinkDepartment of Neuroradiology and Clinical Neuroscience Center, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Nicolaus AndratschkeDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Matthias GuckenbergerDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Marta BogowiczDepartment of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

[This corrects the article DOI: 10.1016/j.phro.2022.05.006.].

Identifiers

PMID35783579
PMCPMC9243153

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.